Hui‐Ming Chang

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Prevention of Heart Failure Induced by Doxorubicin with Early Administration of Dexrazoxane (PHOENIX Study): dose response and time course of dexrazoxane-induced degradation of topoisomerase 2b”.

Prevention of Heart Failure Induced by Doxorubicin with Early Administration of Dexrazoxane (PHOENIX Study): dose response and time course of dexrazoxane-induced degradation of topoisomerase 2b

Cardio-Oncology(2025)10.1186/s40959-025-00339-0

N/A

0.263DataRank · unranked

4 citations

J.C. Hsu, Chul Soo Ahn, Edward T.H. Yeh, Hui‐Ming Chang

Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicin

Cardio-Oncology(2020)10.1186/s40959-019-0056-3

N/A

0DataRank · unranked

38 citations

Hui‐Ming Chang, José Banchs, Dejka M. Araujo, Saamir Hassan, Elizabeth A. Wagar +3 more